Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
0
Participant gender:
All
Summary
This study will examine the bioavailability (the rate and extent to which the active
ingredient or active moiety is absorbed from a drug product and becomes available at the site
of action) of two tablet formulations of Neratinib (HKI-272) compared to the capsule
formulation.